China Resources Pharmaceutical Group Limited (FRA:640)

Germany flag Germany · Delayed Price · Currency is EUR
0.5250
0.00 (0.00%)
Last updated: Sep 9, 2025, 8:20 AM CET
Market Cap3.39B
Revenue (ttm)31.02B
Net Income (ttm)332.79M
Shares Outn/a
EPS (ttm)0.05
PE Ratio10.19
Forward PE7.25
Dividend0.02 (3.21%)
Ex-Dividend DateMay 28, 2025
Volumen/a
Average Volume1,457
Open0.5250
Previous Close0.5250
Day's Range0.5250 - 0.5250
52-Week Range0.5150 - 0.8350
Betan/a
RSI38.74
Earnings DateAug 25, 2025

About FRA:640

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovas... [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 72,700
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 640
Full Company Profile

Financial Performance

In 2024, FRA:640's revenue was 257.67 billion, an increase of 5.30% compared to the previous year's 244.70 billion. Earnings were 3.33 billion, a decrease of -13.57%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.